1 (Tranexamic Acid Infusion Bag Novaplus 1)
Tranexamic Acid In Sodium Chloride Injection, Solution
Product Images NDC 80830-2329
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tranexamic Acid In Sodium Chloride (NDC 80830-2329). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Amneal Pharmaceuticals Private Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
3 (Tranexamic Acid Infusion Bag Novaplus 2)
2 (Tranexamic Acid Infusion Bag Novaplus 3)
This is a medication containing Tranexamic Acid in 0.7% Sodium Chloride Injection. Each 100 mL contains 1,000 mg Tranexamic Acid. It is intended for intravenous infusion only in single-dose containers. The container should be discarded if unused. The solution should be clear before using, and caution is advised to check for leaks and not to add supplemental medication. Storage temperature is recommended to be between 20°C to 25°C. The product is sterile, unpreserved, and nonpyrogenic. The manufacturer is Amneal Pharmaceuticals Pvt Ltd.*
4 (Tranexamic Acid Infusion Bag Novaplus 4)
This text provides information about a medication called Tranexamic Acid in 0.7% Sodium Chloride Injection in single-dose containers. Each 100 mL container contains 1,000 mg of Tranexamic Acid (10 mg per mL). The dosage, storage instructions, cautions, and manufacturer details are also included. The medication is for intravenous infusion only, and it emphasizes the importance of ensuring the solution is clear before use. Instructions for storage include storing between 20°C to 25°C (68°F to 77°F) with excursions permitted between 15°C to 30°C (59°F to 86°F).*
5 (Tranexamic Acid Infusion Bag Novaplus 5)
This text describes a medication containing Tranexamic Acid in 0.7% Sodium Chloride Injection, with each 100 mL container containing 1,000 mg of Tranexamic Acid. It is intended for intravenous infusion only. The product should be stored between 20° to 25°C (68° to 77°F) and precautions include checking for leaks, avoiding adding supplemental medication, and not using in series connections. The manufacturer is Amneal Pharmaceuticals Pvt. Ltd., located in Ahmedabad, India, and it is distributed by Amneal Pharmaceuticals LLC in Bridgewater, New Jersey. The dosing information should be obtained from prescribing information and the product is marked with a batch code for tracking purposes.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
